Aliae

What Aliae does

Aliae is a French Health Tech company founded in 2017 and headquartered in Nancy (Grand East Region), France. It develops conversational AI based on natural language processing and machine learning to collect and analyze patient insights, converting everyday empathetic dialogue into structured quality-of-life and mental-health data equivalent to validated medical questionnaires such as SF36 and PBPI. Its core technology centres on a proprietary multi-chatbot architecture called #ComBot — an assemblage of three chatbots designed to capture weak signals and non-programmed information — together with paraphrasing techniques that address the limited availability of patient-machine dialogue training data. The flagship commercial deployment is eDOL, an e-health application for chronic-pain monitoring developed in partnership with Institut Analgesia and embedded into the bepatient platform, with a 5,000-patient cohort under recruitment as of December 2021.

The company monetises through subscription-based B2B engagements with three customer segments: Contract Research Organisations for advanced patient-reported outcomes in clinical trials, healthcare providers and chronic patients through digital care programs, and insurance companies for prevention, condition-management, and well-being programs. Its go-to-market is enterprise field sales with distribution via direct CRO/insurer contracts and OEM-style platform integration (bepatient). Scientific credibility is anchored in three peer-reviewed publications at top NLP venues (COLING2020, NAACL2021, EMNLP2021), CES 2022 participation, and research collaboration with CNRS and Bpifrance.

Operationally, Aliae remains a very early-stage private company with 1-10 employees, no disclosed equity funding rounds, and revenue that has not been publicly reported, indicating a pre-commercial or pilot-stage posture despite meaningful clinical and academic validation.

Name

Aliae

Legal name

Aliae

Website

https://aliae.io

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Aliae is a French Health Tech company founded in 2017 that builds conversational AI using NLP and machine learning to convert patient dialogue into validated quality-of-life and mental-health data for CROs, healthcare providers, and insurers.

Ownership category

akta.pro rank

Product category

Healthcare AI Software

NAICS

Software Publishers (5132), Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)

akta.pro primary industry

Conversational AI Platforms (chat/voice bots, orchestration) (HDAAAFAC)

akta.pro secondary industries

eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB), Conversational NLP & Dialogue Management (chatbots, agents) (HDAAADAF), EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps (HLACAAAN)

Keywords

• Conversational AI healthcare
• Patient-reported outcomes
• Digital therapeutics
• Clinical trial analytics
• Sentiment analysis software

Headquarters

HQ city

Nancy

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. CRO Clinical Trial Services: Aliae provides conversational AI solutions to Contract Research Organizations for patient-reported outcomes in clinical trials, collecting patient insights and wordings complementary to standard medical questionnaires
2. Digital Care Programs: Revenue from chronic patient care programs delivered through healthcare provider partnerships, providing continuous quality of life monitoring integrated into digital therapeutic offerings
3. Insurance Member Programs: Services to insurers for prevention, medical condition management, and well-being programs for their members

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Aliae develops conversational AI software that engages patients in empathetic dialogue to continuously assess quality of life and mental health. Its technology, including a proprietary three-chatbot assemblage called #ComBot, captures patient insights through natural conversation and translates them into structured medical data, automatically filling validated instruments such as SF36 and PBPI. The platform is sold to Contract Research Organizations for clinical trial patient-reported outcomes, to healthcare providers for chronic disease digital care programs, and to insurers for prevention and well-being programs.

Product overview

Aliae develops conversational AI for patients and healthcare providers (HCPs) as a digital therapeutics (DTX) offer. The core offering consists of Conversational AI technology that transforms natural dialogue with patients into continuous evaluation of quality of life and mental health. Key products include eDOL (an e-health application for chronic pain monitoring developed with Analgesia Institute and bepatient), the Sentiment Analysis Solution using tailored NLP and machine learning, and the Personalized Patient Program based on behavioral science and motivational strategies. The technology serves CROs for clinical trial patient insights, chronic patients in digital care programs, and insurers for prevention and well-being programs.

Differentiator

Problem solved

Functional benefit

Brands

• eDOL: An e-health application developed in partnership with Institut Analgesia and bepatient for monitoring chronic pain patients.
• #ComBot

Products and services

• eDOL e-health application An e-health application for monitoring chronic pain patients, developed in partnership with Institut Analgesia and bepatient. Aliae's Conversational Intelligence technology is integrated into the bepatient platform to provide daily support to chronic pain patients, caregivers, and researchers. The eDol cohort of 5,000 patients was under recruitment as of December 2021.
• Aliae Conversational AI Platform Aliae's core conversational AI technology that reproduces empathetic conversation with patients under real-world assessment conditions. It enables patient involvement and active collaboration through exchange on emotions, thoughts, behaviors, and quality of life for continuous assessment.
• Aliae Sentiment Analysis Solution Tailored Natural Language Processing and machine learning solution that collects, analyzes, and integrates patient insights. Uses specific semantic and sentiment models with a validated linguistic corpus to understand patients' feelings and translate them into actionable data, including automatic medical questionnaire filling (SF36, PBPI).

Quantifiable outcome

• Conversational AI produces equivalent data quality to validated medical questionnaires without requiring patients to fill them out regularly
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability6 records

Feature5 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Institut AnalgesiacoreStrategic or Co-development Partner · 1 December 2021Institut Analgesia is a key strategic partner leading the eDOL e-health application project. Aliae's Conversational Intelligence technology is integrated into the bepatient platform under Analgesia's supervision for monitoring chronic pain in patients, caregivers, and researchers. The partnership includes a 5,000-patient eDol cohort study.
• bepatientcoreTechnology or Integrationbepatient is a patient platform company that hosts Aliae's Conversational Intelligence technology. The integration enables the eDOL application for chronic pain monitoring, providing the technical platform for delivering Aliae's AI-powered patient interactions.
• CNRS (Centre National de la Recherche Scientifique)minorStrategic or Co-development PartnerCNRS is France's national research council. Partnership supports Aliae's scientific research and development of NLP and machine learning technologies for healthcare applications.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Lyra Health: Lyra Health is a broad mental health benefits platform combining technology with provider networks, partially comparable to Aliae's mental health chatbot and employer/insurer channel.
• Babylon Health: Babylon Health delivers AI-driven symptom assessment and virtual care at scale, comparable to Aliae as a chatbot-based patient triage and continuous monitoring provider, though at far greater scale.
• Medidata (Dassault Systèmes): Medidata provides a broad eClinical suite including patient-reported outcomes solutions within larger trial management systems; comparable to Aliae as a CRO-facing PRO data capture vendor.

Emerging players

• Healthily: Healthily (Your.MD) offers AI conversational self-assessment and care navigation, comparable to Aliae's natural-language dialogue approach to patient engagement and symptom capture.
• Ada Health: Ada Health operates a symptom-assessment and patient-engagement chatbot used by insurers and providers, comparable to Aliae's use of conversational AI to convert patient dialogue into structured clinical data.
• Limeade: Limeade is an employee well-being and mental health platform with conversational engagement, comparable to Aliae's insurer-facing prevention and well-being programs.
• Medable: Medable enables decentralized clinical trials with patient-facing digital tools and eCOA, comparable to Aliae's eDOL chronic pain patient monitoring and remote patient engagement approach.

Direct peers

• Wysa: Wysa is an AI-chatbot mental health platform serving payers, providers, and employers with conversational emotional support, paralleling Aliae's NLP-driven patient engagement and sentiment analysis capabilities.
• Clario: Clario is the leading eCOA/ePRO vendor for clinical trials, addressing the same CRO patient-reported outcomes use case as Aliae's conversational AI for trial-based quality-of-life capture.
• Woebot Health: Woebot Health builds an AI-driven conversational mental health platform using NLP to deliver CBT and emotional support via chat, directly comparable to Aliae's empathetic chatbot approach for mental health and quality-of-life monitoring.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/aliae

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aliae